Denali Therapeutics, Inc. (DNLI)
19.38
-1.27
(-6.15%)
USD |
NASDAQ |
Apr 06, 16:00
19.43
+0.05
(+0.26%)
After-Hours: 05:34
Denali Therapeutics SG&A Expense (TTM) : 136.56M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Protalix Biotherapeutics, Inc. | 11.68M |
| Agenus, Inc. | 54.39M |
| Curis, Inc. | 14.05M |
| Plus Therapeutics, Inc. | 12.13M |
| Windtree Therapeutics, Inc. | 7.706M |